The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Ruby-Fill
Rubidium Rb 82 · RUBIDIUM CHLORIDE RB-82 100 mCi/1 · Injection, Solution · Intravenous · Jubilant DraxImage Inc., dba Jubilant Radiopharma
NDC 65174-0021-10 · 1 INJECTION, SOLUTION in 1 CONTAINER · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA202153
- TE code
- —
- Approval date
- Sep 30, 2016
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Rubidium Rb 82 (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Jubilant DraxImage Inc., dba Jubilant Radiopharma | RUBIDIUM CHLORIDE RB-82 100 mCi/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Ruby-Fill — NDC 65174-0021-10," retrieved September 3, 2026, https://drugdashboards.com/drug/65174002110.
Free to cite with attribution — see how the data is put together.